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PRECLINICAL STUDIES
eal-Time Detection and Alerting for Acute
T-Segment Elevation Myocardial Ischemia
sing an Implantable, High-Fidelity, Intracardiac
lectrogram Monitoring System With Long-Range
elemetry in an Ambulatory Porcine Model
im A. Fischell, MD, FACC,* David R. Fischell, PHD,† Robert E. Fischell, DSC,† Renu Virmani, MD,‡
ennifer J. DeVries, LATG, SRS,§ Mitchell W. Krucoff, MD, FACC
alamazoo and Mattawan, Michigan; Tinton Falls, New Jersey; Gaithersburg, Maryland;
nd Durham, North Carolina
OBJECTIVES The purpose of this study was to evaluate feasibility of using real-time, high-fidelity,
intracardiac electrogram monitoring from a permanently implantable ischemia detection
system (IIDS), with long-range telemetry capability to detect ST-segment shifts associated
with acute or subacute coronary occlusion in a porcine model.
BACKGROUND Early identification of coronary occlusion with ST-segment elevation could profoundly
accelerate the timing of revascularization and improve clinical outcomes.
METHODS This paper reports the first investigation using real-time, high-fidelity, intracardiac electro-
gram monitoring from a permanently IIDS, with long-range telemetry capability. This IIDS
was tested in an ambulatory porcine model, with acute coronary occlusion precipitated by
stent thrombosis. Two overlapping copper stents were implanted in the left anterior
descending (n  3), the circumflex (n  3), or the right coronary artery (n  2) of juvenile
farm pigs. Monitoring was carried using telemetry from the IIDS.
RESULTS All stented pigs had acute ST-segment elevation event(s) triggering the alerting thresholds of
the IIDS. All triggered events were confirmed to be caused by thrombosis of the copper
stent(s), and well correlated to infarct age and location. Four of the 8 pigs died from
ventricular fibrillation, recorded by the IIDS at a mean time of 70  121 h after ST-segment
alert. The sensitivity and specificity of alerting for ST-segment shift, associated with
thrombotic coronary occlusion, were 100% and 100%, respectively.
CONCLUSIONS This study demonstrates the ability of an implantable ischemia detection system to detect
ST-segment elevation from coronary occlusion in a porcine model of ST-segment elevation
myocardial infarction. ST-segment elevation was sufficient to trigger alerting thresholds in all
3 epicardial coronary distributions. Such a system, with real-time alerting capability, could
advance the time frame of reperfusion therapy and potentially prevent, rather than interrupt,
acute myocardial infarction in patients with coronary artery disease. (J Am Coll Cardiol
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.07.0582006;48:2306–14) © 2006 by the American College of Cardiology Foundation
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mcute myocardial infarction (MI) remains the leading cause
f mortality in the Western world (1). Early detection and
arning of acute MI, or antecedent ischemic events, and
rompt intervention can substantially improve clinical out-
omes (2–9). However, despite efforts at educating the
ublic over the past decade, the mean time from MI
ymptom onset to arrival at a hospital for treatment has
emained, disappointingly, at 2.5 to 3.0 h (3,8–12). Con-
inued delays in door-to-balloon time typically exceed 2 h,
o lead to further myocardial necrosis and poorer clinical
utcomes (13,14).
From *Borgess Heart Institute, Kalamazoo, Michigan; †AngelMed Systems, Inc.,
inton Falls, New Jersey; ‡CV Path, Gaithersburg, Maryland; §MPI Research,
attawan, Michigan; and Duke Clinical Research Institute/Duke University Med-
cal Center, Durham, North Carolina. Supported, in part, by a grant from AngelMed
ystems, Inc., Tinton Falls, New Jersey.m
Manuscript received January 6, 2006; revised manuscript received June 15, 2006,
ccepted July 23, 2006.Because a large proportion of irreversible myocardial
njury and fatal ventricular arrhythmias occur in the first
everal hours after closure of an epicardial coronary artery, it
ay be difficult to substantially improve upon our treatment
f MI unless we can make an early and reliable diagnosis of
he acute MI (3,8–20).
Previous testing of this concept in patients, using an intra-
ardiac electrogram (ICEG) obtained from a skin electrode on
he left upper chest to a temporary (pacemaker) electrode in the
ight ventricular apex has demonstrated consistent, rapidly
volving, and dramatic ST-segment shifts during balloon
cclusion during percutaneous coronary intervention (PCI) in
umans (16,17,21,22). Permanently implanted leads have the
dvantage of being free from ST-segment artifact, muscle
oise, transthoracic damping, or concerns about electrode
ovement over the course of electrocardiogram (ECG)
onitoring.
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December 5, 2006:2306–14 Feasibility of an Implantable Ischemia Detection SystemThe current device monitors the ICEG 24 h a day 7 days
week. If any new ischemic event (either heart-rate-related
T-segment depression or sudden ST-segment elevation)
ccurs, the device will alert the patient with a buzzing from
he device. It is expected that patients with such a device
ould immediately call their physician, and/or 911 upon
etting such an ischemic alert. This early alerting capability
ould be used to improve the time to treatment, and
utcomes, in high-risk coronary artery disease patients with
T-segment elevation MI (STEMI).
The purpose of this study was to expand upon the early
uman feasibility testing that utilized temporary pacemaker
eads during PCI in supine patients. In this study, we report
he first findings from a fully implantable, high-fidelity
CEG monitoring system, with programmable ST-segment
levation ischemia detection and alerting thresholds, and
ith long-range telemetry capability. This system was tested
sing the tip electrode from a permanent apical right
entricular (pacemaker) lead attached to the implantable
schemia detection system (IIDS), in an ambulatory, porcine
opper stent, STEMI model (23).
ETHODS
IDS. This study was designed to evaluate the feasibility of a
rogrammable, implantable device to provide early detection
nd alerts for transmural ischemia (sudden ST-segment eleva-
ion). The individual components of the IIDS include a
acemaker-sized implanted medical device (IMD), a standard
igure 1. Photographs showing the various components of the implantabl
VI pacemaker, is shown, attached to the lead adapter and a standard b
Abbreviations and Acronyms
EXD  external alerting device
ICEG  intracardiac electrogram
IIDS  implantable ischemia detection system
IMD  implanted medical device
MI  myocardial infarction
PCI  percutaneous coronary intervention
STEMI  ST-segment elevation myocardial infarctionttached to the laptop computer, which is used for programming and data collect
evice has 2 light-emitting diodes: red light for emergency alerts and yellow ligipolar “screw in” pacemaker lead, a lead adaptor containing
he long-range telemetry antenna, a small portable external
lerting device (EXD), and a laptop computer programmer to
et event detection parameters and display the electrical signals
ecorded by the IMD. The components of the system are
hown in Figure 1. This device is implanted is a manner
nalogous to a single-chamber pacemaker.
The programmer utilizes the EXD to provide wireless
ata connectivity to the IMD. The IMD attaches to a
tandard bipolar pacemaker lead with a lead adapter as
hown in Figure 1. The lead adapter includes the antenna
or EXD to IMD communication. This has a transmission
ange of 6 to 8 feet.
The IMD monitors the ICEG signal from the heart
can-to-tip ICEG) for ischemic ST-segment shift, by mea-
uring the level of the ST-segment versus P-Q segment
Fig. 2). The IMD analyzes 10 consecutive QRST com-
lexes every 30 s. This 10 beats every 30 s sampling is done
o provide a close to “real-time” detection of events but with
ntent to conserve the implant’s battery life. For each beat,
he IMD computes the average value of ST-segment
oltage. The algorithm then uses the subject’s own baseline
T-segment voltage relative to the P-Q segment, measured
4 h previously, as the “control” signal for ST-segment shift
omparisons. An appropriate heart-rate-matched “baseline”
s examined as close to 24 h as possible if the control
T-segment is in a different heart rate bin. If ST-segment
hift is detected in 8 of 10 analyzable beats, in 3 consecutive
0-s periods, this will set off the appropriate (programmed)
lert. The requirement for detection of programmed thresh-
ld ST-segment shift in 8 of 10 beats in 3 consecutive
amples is intended to reduce the likelihood of “false-
ositive” alerts. If at least 6 of 6 analyzable beats have
xcessive ST-segment shift in 3 successive 10-s segments,
hen an ST-segment shift alert can be activated, either with
ibration of the IMD (like a cell phone) within the IMD
ase, or through an EXD to provide an additional auditory
lert (beeps) and/or visual alert such as flashing light-
emia detection system. (A) The implantable medical device, resembling a
, screw-in, right ventricular lead. (B) Shows the external alerting devicee isch
ipolarion, via telemetry to the implantable medical device. The external alerting
ht for “see your physician” alerts.
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Feasibility of an Implantable Ischemia Detection System December 5, 2006:2306–14mitting diodes. Eventually this system could also be con-
ected to a cellular-based service network.
Once an alert is initiated, ICEG segments related to the
lert are saved by the IMD and can be retrieved for review
y a physician using the programmer. The IMD is also
apable of capturing ICEG data without alerting, when
ifferent cardiac events such as a low or an irregular heart
ate is detected. There are other sophisticated programma-
le features that will not be addressed in detail in the current
aper. For the purposes of this report, only the ST-segment
eviation alerts were tested, with a threshold of 30%
T-segment shift relative to QRS height programmed as a
ignificant ST-segment shift. This 30% threshold was
hosen based upon the data from our previously published
linical data with temporary electrodes during PCI (16). No
eperfusion therapy was attempted in this protocol.
nimal protocol. A total of 10 juvenile farm swine
Landrace-Duroc Yorkshire cross), weighing 30 to 40 kg, were
sed in this protocol. The protocol was reviewed and approved
y the MPI Research Institutional Animal Care and Use
ommittee, and was performed at a major Good Laboratory
ractices certified animal research facility (MPI Research) in
attawan, Michigan. The study conformed to the “Position of
he American Heart Association on Research Animal Use”
dopted by the Association in November 1994.
cute IIDS implants. Animals were pre-treated with
spirin, 325 mg, clopidogrel, 75 mg, and nifedipine, 30 mg,
efore IMD implant. General anesthesia was performed,
ith endotracheal intubation and medications per protocol.
he medications included atropine, 0.05 mg/kg, telazol, 8
g/kg intramuscularly, isoflurane by inhalation, cefazolin,
0 mg/kg intravenously, and fentanyl patch, 50 to 75 g/kg
ransdermally, post-operatively.
The IMD was implanted in the same manner as a
ingle-chamber pacemaker. The IMD was attached to a St.
ude Medical (Sylmar, California) bipolar pacemaker lead.
his steroid eluting, screw-in lead was inserted trans-
igure 2. Illustration showing computer-based analysis of ST-segment shif
cclusion (Table 1, pig 6). (A) Shows minor ST-segment depression in th
hows a net 51% ST-segment shift, relative to baseline, and normalized t
anually shifted the P-Q segment to precede the actual Q-wave, as detecenously using standard lead implantation techniques after iut-down in the animals’ left lower neck to access the left
nternal jugular. The lead tip was carefully positioned at the
ight ventricular apex, under fluoroscopic guidance, and
hen secured using the standard “screw-in” lead technique.
ue to the anatomy of the juvenile swine, the IMD, in the
urrent study, was implanted in the left lower neck of the
ig. In humans, the IMD would be placed in the preferred
osition, in the left upper chest (16). The lead was attached,
sing the antenna/lead adapter, to the IMD. Baseline
control) ICEG data were retrieved via telemetry to the
XD over the next 24 to 72 h.
opper stent implants. At 24 to 72 h after IMD implan-
ation, 8 of the animals were brought back to the animal
atheterization suite for copper stent placement. The other
animals served as controls. For the animals receiving
tents, general anesthesia and pre-medication were admin-
stered as in the preceding text. After cut-down, a 7-F
heath was placed in the right common carotid artery.
ntravenous heparin was administered to achieve an acti-
ated clotting time of 150 s. The pig’s right or left
oronary artery was engaged using a 7-F JR3 coronary
uiding catheter. The target vessel for stenting in each pig
as predetermined by random assignment. Three animals
ad stenting of the left anterior descending, 3 animals had
tenting of the left circumflex, and 2 animals had stenting of
he right coronary artery. In each case, 2 custom made,
opper, 18-mm length, balloon expandable stents were
mplanted in tandem fashion in the target vessel, with
pproximately 3 to 4 mm of stent overlap. The stents were
mplanted at 12 atms inflation pressure, with either a 3.0- or
.5-mm diameter balloon, with inflation time ranging from
to 4 min. This copper stent model has been shown to be
reproducible model for subacute stent thrombosis, and
spontaneous” STEMI (20).
n lab ST-segment recordings. Both 12-lead ECG and
CEG ST-segment recordings were obtained in 6 of the 8
nimals during the acute stent implantation (2-min balloon
animal with acute ST-segment elevation associated with a left circumflex
line QRST, followed the next day by sudden ST-segment elevation. This
QRS height. It should be noted that the programmer, in this example,
y the implantable ischemia detection system by approximately 30 ms.t in an
e base
o thenflations) (Table 1). In 2 animals, surface lead data had too
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December 5, 2006:2306–14 Feasibility of an Implantable Ischemia Detection Systemuch artifact for interpretation. After stent implantation,
he animals were recovered, and baseline ICEG data were
ownloaded. All antiplatelet agents were discontinued after
he stent implantation.
Two juvenile swine had IMD implants, without any
oronary manipulation. No stents were placed in these
nimals so that they could serve as controls, specifically
ooking for false-positive ST-segment alerts in these ambu-
atory animals over 28 days of follow-up. In addition,
aseline ICEG data from the stented pigs were monitored
or 24 to 72 h before stent placement, to gather additional
control” ICEG data.
CEG monitoring. After recovery, the animals were ob-
erved in holding cages with the EXD mounted within 6 to 8
eet of the animal for downloading of ICEG data. Formal data
ownloads were performed a minimum of 2 times/day, until
nimal death or sacrifice. All event-related IMD data were
ownloaded and analyzed to get detailed assessment of the
T-segment shift events (Fig. 2), and fatal arrhythmic events.
he exact time-based relationship(s) of these events were easily
ccessed via the download of the IMD data. Surface ECG data
ere not obtained during the ambulatory period because the
nimals do not tolerate this type of monitoring.
Four of the 8 animals with copper stents died from
entricular fibrillation before 26 days. Repeat coronary
ngiography was performed before animal sacrifice in 3 of
he 4 surviving animals. It was not feasible to perform
nesthesia during ischemic events in the ambulatory ani-
als, and no interventions were performed to interrupt the
etected STEMIs. All 8 animals had a detailed cardiac
ecropsy study to assess both coronary patency and MI(s).
athologic data collection. All 8 animals with copper
tent implants underwent detailed cardiac necropsy exami-
ation. The pathologists were blinded to the time of death
elative to STEMI or stent implant. The pathologists were
sked to provide qualitative age estimation, and the regional
ocalization of any MI observed at necropsy.
Before processing the hearts, digital photographs and
able 1. Electrogram Results in Porcine Coronary Occlusion Mo
Pig #
Vessel
Stented
Time From
Stent
Implant to
STEMI
Detection
(h)
Time From
STEMI to
VF/Death
(h)
% ST-Se
Shift D
Stent Im
EC
(vs. QRS
1 LAD 59 1.1 NA
2 LAD 29 53 28
3 LAD 3 0.6 35
4 LCX 77 NA NA
5 LCX 45 NA 12
6 LCX 7 NA 16
7 RCA 33 264 26
8 RCA 17 NA 14
Mean  SD 34  19 79  121 22 
CG  surface electrocardiogram; h  hours; ICEG  intracardiac electrogram; L
vailable; RCA  right coronary artery; STEMI  ST-segment elevation myocardiadiographs were obtained to document gross findings and no assess device and stent placement. For assessment of
yocardial infarcts/scars, the hearts were “bread-loafed”
rom base to apex at 1-cm intervals.
Stented vessel segments were dehydrated in a graded
eries of ethanol and embedded in methylmethacrylate
lastic. Sections from the stents were then cut on a rotary
icrotome at 4 to 5 m, mounted and stained with
ematoxylin and eosin and elastic Van Gieson stains. All
yocardial sections were embedded in paraffin, cut on a
otary microtome, mounted on glass slides, and stained with
&E and Masson’s trichrome stains.
ata analysis. All ICEG recordings were stored from IMD
ownloads for subsequent analysis. A caliper-based, manual
ethod (16) was used to measure the ST-segment shift
ompared with the PR segment at each of the following time
oints: baseline (before stenting); after 2 min of balloon
nflation for both IMD and limb lead tracings (n  5); at the
ime of the first automated ST-segment alarm; and at the peak
T-segment elevation detected before death or sacrifice.
tatistics. The ST-segment data and the QRS amplitude
ata were recorded in mm (mV) using Excel spreadsheets
Microsoft Corp., Bellevue, Washington). After raw data
ntry, this software was used to calculate % ST-segment
hange relative to baseline QRS amplitude at each time
oint. The statistical package from Excel (Microsoft Corp.)
as used for statistical comparisons. The % ST-segment
hange at each time point was compared to baseline
easurements using analysis of variance for repeated mea-
ures. This methodology was also used to compare the %
T-segment change between the surface (limb) lead and the
ntracardiac lead in the 5 animals with simultaneous mea-
urement during stent implantation. All data in tables and
n figures are shown as mean  SD. Sensitivity was defined
s the number of animals with ST-segment shift causing
mergency alert from the IMD with timing consistent with
ngiographic or pathologic evidence of occlusion and/or
nfarction divided by documented coronary occlusions.
pecificity was defined by the incidence/probability of
t
t,
ht)
% ST-Segment
Shift During
Stent Implant,
ICEG
(vs. QRS Height)
% ST-Segment
Shift During
First STEMI
Event
(vs. QRS Height)
Peak
% ST-Segment
Shift During
STEMI
(vs. QRS Height)
NA 50 50
36 33 73
43 68 86
NA 36 47
29 38 72
28 41 51
38 45 64
24 29 89
33  7 39  6 67  15
left anterior descending coronary artery; LCX  left circumflex artery; NA  not
ction; VF  ventricular fibrillation.del
gmen
uring
plan
G
Heig
8egative monitoring (i.e., no alerting ST-segment shifts)
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Feasibility of an Implantable Ischemia Detection System December 5, 2006:2306–14mong animals without coronary occlusion. A p value of
0.05 was considered statistically significant.
ESULTS
lectrogram data and STEMI in copper-stented animals.
ll 10 animals had stable intracardiac ICEGs at 24 h after
MD implant. There was minor ST-segment shift imme-
iately after the right ventricle lead implants in 4 of 10
nimals. This local “injury current” effect resolved by 24 h
fter permanent right ventricle lead implants in this model.
here were no false positive ST-segment shift events from
he IMD monitoring before stent implantation.
In 2 control animals, no coronary stenting was performed
fter IMD implantation. There were no false-positive ST-
egment shift events in these animals over the 30 days of
onitoring.
In the 6 animals with simultaneous recording of ICEGs
nd surface leads during stent implantation, there was a
ore prominent ST-segment shift after 2 min of balloon
igure 3. Illustration of acute ST-segment changes and spontaneous ST-se
racings were obtained from telemetry from implantable cardiac device
T-segment shift at baseline 30 h after medical device implant. (B) H
T-segment depression sets off a “see your physician” alert 13 h after c
T-segment elevation is noted at 59 h after copper stent implantation, res
remature beats, leading to ventricular fibrillation 1 h after the initial ST-segm
5 min after the initial ventricular fibrillation (G).nflation from the intracardiac recording (33  7%) com-
ared with greatest ST-segment shift observed in any of the
imb leads (22  8%; p  0.05 vs. intracardiac ST-segment
hift) (Table 1). The mean ST-segment shift from sponta-
eous coronary occlusion, at the time that the emergency
lert was activated, was 48% for the left anterior descending
oronary artery, 38% for the left circumflex coronary artery,
nd 37% for the right coronary artery (all p values  NS).
All 8 stented animals demonstrated spontaneous and rapidly
volving ST-segment shift events between 3 and 77 h after
opper stent implant. All of these events were consistent with
ubacute stent thrombosis and an associated STEMI (Table
). The mean time from copper stent implant to the first
T-segment elevation emergency alert was 34  19 h. The %
T-segment shift relative to baseline QRS amplitude, at the
ime of the first emergency ST-segment shift alert was 39 
% (p 0.001 vs. baseline ST-segment shift). It should also be
oted that there was continued evolution of ST-segment shift
bserved in all 8 animals after the initial alerting detection. The
t elevation myocardial infarction as recorded by implanted medical device.
xternal alerting device. (A) Shows stable normal sinus rhythm without
ate-related (heart rate increase from 119 at baseline to 148 beats/min)
stent implantation in the left anterior descending coronary artery. (C)
in an “emergency” alert. (D and E) There are more frequent ventriculargmen
to e
eart r
opper
ultingent emergency alert (F). The animal passed away with an agonal rhythm
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December 5, 2006:2306–14 Feasibility of an Implantable Ischemia Detection Systemeak ST-segment shift observed via IMD telemetry was 67
5% (p  0.0001 vs. baseline ST-segment shift) before
acrifice or death (n  8).
Four of the 8 pigs died from ventricular fibrillation, all
ecorded by the IMD, before the scheduled 26- to 28-day
acrifice. The mean time from ST-segment elevation emer-
ency alert to ventricular fibrillation/death was 70  121 h.
wo examples of ST-segment elevation, followed by ven-
igure 4. Illustration of acute ST-segment changes and spontaneous ST-se
racings were obtained from telemetry from implantable cardiac device
T-segment shift at baseline 26 h after medical device implant. (B) ST-
mplantation in the left anterior descending coronary artery. (C) The anim
oronary artery stent implant. External cardioversion/defibrillation is perfor
edical device. After 4 min of recovery, the intracardiac electrogram returnvolution to marked ST-segment elevation (72% vs. QRS amplitude, E) with
yocardial infarction, the animal develops spontaneous ventricular fibrillation (ricular fibrillation, are shown from the downloaded ICEGs
n Figures 3 and 4.
Table 2 provides a summary of the time from automated
T-segment shift detection to death or sacrifice, and correlates
hese observations with the necropsy findings. There was a
ood correlation between the estimated age of MI and the
essel status by pathology, and by timing from first STEMI
mergency alerting event via the IMD telemetry data.
t elevation myocardial infarction as recorded by implanted medical device.
xternal alerting device. (A) Shows stable normal sinus rhythm without
nt elevation is noted after 90 s of balloon inflation, during copper stent
veloped ventricular fibrillation at 120 s into the left anterior descending
ith 300 J (square wave in C), without deleterious effect on the implanted
aseline (D). At 3 h after copper stent implant, the electrogram shows rapidgmen
to e
segme
al de
med w
s to bemergency alert. Within 30 min from onset of ST-segment elevation
F) and then expires, with a flat line tracing (G).
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Feasibility of an Implantable Ischemia Detection System December 5, 2006:2306–14Figure 5 shows an illustration of ST-segment elevation
ecorded from the IMD during a (presumed) left circumflex
cclusion 77 h after copper stent implantation. In this case,
he animal recovered, with restabilization of the intracardiac
CEG. At angiography and necropsy 23 days later, the
nimal was demonstrated to have total thrombotic occlusion
f the circumflex stents with a transmural lateral MI,
stimated to be between 15 and 30 days old.
ISCUSSION
his study demonstrates the feasibility of using an intracar-
iac, right ventricular apical lead to detect ST-segment shift
n the setting of sudden epicardial coronary artery occlusion
n a copper stent, porcine model.
It is important to recognize that the only documented
able 2. Correlation of Electrogram Data With Necropsy Findin
Pig #
Vessel
Stented
Survival
to 28
Days
Time STEMI
to VF/Death
(h)
T
D
o
1 LAD No 1.1
2 LAD No 0.6
3 LAD No 53
4 LCX Yes Survived MI
5 LCX Yes Survived MI
6 LCX Yes Survived MI
7 RCA No 264
8 RCA Yes Survived MI
d:hh  # days:# hours; ICEG  intracardiac electrogram; IIDS  implantable i
ircumflex artery; MI  myocardial infarction; NA  not available; RCA  right c
brillation.ause of rapidly progressive ST-segment elevation in hu- sans is total and abrupt coronary occlusion (e.g., by
alloon, thrombus, spasm, or other). Thus, the current
odel closely mimics the pathophysiology of coronary
cclusion preceding and leading to acute MI in patients
ith coronary artery disease.
The clinical relevance of the observations made in this
tudy may be viewed in the context of our current failure to
chieve early diagnosis and treatment of acute MI. Despite
dvances in pharmacologic and mechanical means of coro-
ary revascularization (4–7,13), the average time between
nset of symptoms during acute MI and the arrival at a
edical facility capable of either pharmacologic or mechan-
cal revascularization is 2.5 to 3 h. This patient-related delay
s problematic, and most often related to denial of symp-
oms, embarrassment, and/or misinterpretation of atypical
rom STEMI
on To Death
rifice (dd:hh)
Angiographic and/or
Pathology of
Stented Vessel
Cardiac Pathology
at Autopsy
00:01 No Angio 75%
occluded; layers of
thrombus
Focal areas of early
ischemia anterior
wall; myocyte
hypereosinophilia,
nuclear
chromatin
condensation
00:00.6 No Angio 35%
occluded;
unorganized
thrombus
Early ischemia;
mild interstitial
lymphocytic
infiltrate anterior
wall
02:05 No Angio 91%
occluded; organized
thrombus
Transmural
anterior and
anteroseptal MI
“4–6 days old”
23:21 Occluded with
organized thrombus
Transmural
posterior, lateral
wall MI at least
15–30 days old
27:17 Occluded with
organized thrombus
Transmural
posterior, lateral
wall MI at least
15–30 days old
26:21 Occluded with
organized thrombus
Transmural
posterior, lateral
wall MI at least
15–30 days old
13:03 No Angio occluded
with organized
thrombus
Transmural
posterior MI at
least 10–15 days
old
26:19 Occluded with
organized thrombus
Transmural
posterior-septal,
and right
ventricular MI at
least 15–30 days
old
ia detection system; LAD  left anterior descending coronary artery; LCX  left
y artery; STEMI  ST-segment elevation myocardial infarction; VF  ventriculargs
ime F
etecti
r Sac
schemymptoms (3,8,9–12). Additional major delays are com-
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2,12–14). Thus, the mean time from symptom onset to
evascularization often exceeds 5 h. Delays in treatment are
ven more frequent, and potentially deadly for patients who
xperience atypical symptoms or no cardiac symptoms
“silent MI”) (2,12,15). This presentation is most common
n diabetic patients, women, and the elderly. These “sub-
roups” comprise a substantial proportion of our aging
opulation who are at risk for acute MI (1,2). Finally, a
umber of studies have clearly demonstrated the important
elationship between the time from vessel closure to revas-
ularization, and the clinical outcome after acute MI (2–9).
Given these challenges, it may be difficult to substantially
mprove upon our treatment of acute MI unless we can
ake an earlier and reliable diagnosis. The observations
rom this study suggest that a simple implantable device
ith a configuration similar to today’s VVI pacemakers
ould be capable of such “early” ischemia detection.
The configuration of the intracardiac lead system in this
tudy is analogous to most contemporary permanent pace-
akers and automatic implantable cardiac defibrillators).
he rapid evolution of ICEG-detected ST-segment eleva-
ion in the current study is consistent with the clinical
igure 5. Illustration of acute ST-segment changes recorded by implanted
inus rhythm without ST-segment shift at baseline 30 h after implanted m
lert with pronounced ST-segment elevation 77 h after copper stent impla
2 h after the alerting ST-segment elevation event. Angiography immedia
D) shows patency of left circumflex coronary artery (white arrows). Th
ngiography (white arrows, E) and histopathology (black arrows show infl
t 26 days after copper stent implant. Inflammation, with layers of occlusi
ateral and posterior transmural myocardial infarction (stained in blue) atbservations using a temporary right ventricular pacemaker Tead during PCI, as reported by Varriale and Niznik (17),
ischell et al. (16), and others (19,21,22).
In the current study, we observed a substantial ST-
egment shift (34%, relative to the QRS amplitude) within
min of balloon occlusion in an epicardial coronary artery
f animals undergoing stent implantation. The magnitude
f ST-segment shift relative to the QRS amplitude was
reater for the intracardiac lead than for the surface leads,
ecorded during stent implantation. These data are similar
o the recent human studies by Theres et al. (22), and our
roup (16), suggesting that intracardiac ICEG recordings
ay be superior to surface leads in detecting myocardial
schemia. Based upon our prior human experience (16), we
elieve that the detection of left circumflex coronary artery
nd right coronary artery events may be further enhanced
ith implantation of the second electrode (“can”) in the left
pper chest, as opposed to the left neck, as was required in
hese porcine experiments.
tudy limitations. This is an animal study intended to
xamine the feasibility of using an implantable, program-
able, ischemia detection and alerting system to detect,
ecord, and alert upon the recognition of a significant
T-segment shift during spontaneous coronary occlusion.
al device, and correlation with necropsy findings. (A) Shows stable normal
l device implant. (B) The animal receives an emergency ST-segment shift
n in the left circumflex coronary artery. (C) The ST-segment resolves at
fter copper stent implants in the proximal left circumflex coronary artery
ts appear totally occluded at 25 days after copper stent implant by both
tion around struts of copper stent) (F). The animal survived until sacrifice
ombus with minor recanalization channels, is observed (F). (G) Shows a
ys after stent implant (black arrows).medic
edica
ntatio
tely a
e sten
ammahese data were collected after implantation of copper
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TEMI. The results obtained using this methodology may
ot exactly replicate the ST-segment changes that would be
bserved in patients with STEMI from thrombosis in the
etting of chronic, atherosclerotic coronary heart disease.
lthough first-in-man clinical testing is planned, we do not
ave data from permanent implants, in humans, to evaluate
he stability of the intracardiac ICEG or its sensitivity or
pecificity in detecting coronary occlusion. However, the
00% sensitivity and specificity of ST-segment shift alerts
orrelating with coronary artery thrombotic occlusion, in
his model, is encouraging.
onclusions. This study confirms the feasibility of using
n implantable, programmable, ischemia detection and
lerting system (IIDS) to assist in the diagnosis of an
TEMI caused by subacute stent thrombosis. These results,
ombined with prior clinical observations (16,17,21,22),
uggest that a relatively simple, implantable system, resem-
ling a VVI pacemaker (16,24), could be programmed to
ssist in the early diagnosis of acute STEMI and/or ante-
edent ischemic events. The potential to identify human
oronary occlusion within seconds of its onset, and provide
mmediate mechanical alerting to the patient, could shift the
ntire paradigm of care from (current) interruption of MI,
o the prevention of myocardial necrosis.
Although a number of technical and clinical questions
emain to be addressed by future work, this report suggests that
ntracardiac ST-segment monitoring, with an alerting capabil-
ty, could be used to improve the time to treatment, and
utcomes, in high-risk coronary artery disease patients with
TEMI.
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